Jilin Jian Yisheng Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 13.32%

Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has an Asset Resilience Ratio of 13.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥400.57 Million

≈ $58.62 Million USD Cash + Short-term Investments

Total Assets

CN¥3.01 Billion

≈ $439.90 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Jilin Jian Yisheng Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Jilin Jian Yisheng Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jilin Jian Yisheng Pharmaceutical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥400.57 Million	13.32%
Total Liquid Assets	CN¥400.57 Million	13.32%

Asset Resilience Insights

Moderate Liquidity: Jilin Jian Yisheng Pharmaceutical Co Ltd has 13.32% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Jilin Jian Yisheng Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jilin Jian Yisheng Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
Galapagos NV F:GXEA	Biotechnology	86.45%
Nanobiotix S.A PA:NANO	Biotechnology	53.40%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	34.30%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Jilin Jian Yisheng Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	17.15%	CN¥507.57 Million ≈ $74.27 Million	CN¥2.96 Billion ≈ $433.09 Million	+1.68pp
2024-12-31	15.47%	CN¥459.67 Million ≈ $67.26 Million	CN¥2.97 Billion ≈ $434.70 Million	+12.09pp
2023-12-31	3.38%	CN¥102.98 Million ≈ $15.07 Million	CN¥3.05 Billion ≈ $445.83 Million	+1.36pp
2022-12-31	2.02%	CN¥59.84 Million ≈ $8.76 Million	CN¥2.97 Billion ≈ $434.11 Million	-0.43pp
2021-12-31	2.45%	CN¥70.16 Million ≈ $10.27 Million	CN¥2.86 Billion ≈ $419.15 Million	+2.30pp
2017-12-31	0.15%	CN¥4.00 Million ≈ $585.33K	CN¥2.65 Billion ≈ $388.29 Million	-1.10pp
2015-12-31	1.25%	CN¥33.00 Million ≈ $4.83 Million	CN¥2.63 Billion ≈ $385.40 Million	-2.04pp
2014-12-31	3.29%	CN¥82.00 Million ≈ $12.00 Million	CN¥2.49 Billion ≈ $364.42 Million	+3.21pp
2006-12-31	0.08%	CN¥269.00K ≈ $39.36K	CN¥338.04 Million ≈ $49.47 Million	--

pp = percentage points

About Jilin Jian Yisheng Pharmaceutical Co Ltd

SHE:002566 China Biotechnology

Market Cap

$318.18 Million

CN¥2.17 Billion CNY

Market Cap Rank

#14530 Global

#4328 in China

Share Price

CN¥6.57

Change (1 day)

+1.55%

52-Week Range

CN¥5.82 - CN¥9.05

All Time High

CN¥19.38